Consun Pharmaceutical Group Limited (HKG:1681)

HKG:1681 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,457	6,771	3,780	3,193	3,495	2,439
Market Cap Growth	105.04%	79.14%	18.38%	-8.64%	43.27%	-37.84%
Enterprise Value	8,636	3,788	1,258	1,225	2,132	1,743
Last Close Price	15.03	7.94	3.99	3.10	3.20	2.09
PE Ratio	11.65	6.99	4.37	4.14	4.82	4.12
Forward PE	10.74	4.81	4.09	4.18	3.80	3.76
PS Ratio	3.48	2.14	1.33	1.21	1.39	1.17
PB Ratio	2.45	1.45	0.88	0.82	0.98	0.82
P/TBV Ratio	2.78	1.66	1.03	1.00	1.25	1.11
P/FCF Ratio	-	6.51	4.48	3.15	4.54	2.51
P/OCF Ratio	-	5.85	4.19	2.98	3.92	2.37
PEG Ratio	-	0.27	0.27	0.27	0.27	0.27
EV/Sales Ratio	2.41	1.20	0.44	0.46	0.85	0.84
EV/EBITDA Ratio	7.03	3.45	1.27	1.38	2.38	2.37
EV/EBIT Ratio	7.35	3.65	1.38	1.51	2.63	2.67
EV/FCF Ratio	-	3.64	1.49	1.21	2.77	1.79
Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.21	0.22
Debt / EBITDA Ratio	0.23	0.26	0.57	0.58	0.83	0.88
Debt / FCF Ratio	-	0.27	0.67	0.51	0.97	0.67
Asset Turnover	0.56	0.52	0.50	0.51	0.49	0.46
Inventory Turnover	2.35	2.07	1.99	2.12	2.13	1.97
Quick Ratio	3.29	3.09	2.60	2.47	2.06	1.80
Current Ratio	3.54	3.32	2.86	2.68	2.25	2.00
Return on Equity (ROE)	23.60%	22.07%	21.38%	21.53%	21.64%	19.98%
Return on Assets (ROA)	11.58%	10.73%	9.93%	9.66%	9.93%	8.98%
Return on Capital (ROIC)	14.26%	13.41%	12.39%	12.05%	12.53%	11.60%
Return on Capital Employed (ROCE)	22.60%	21.80%	20.60%	20.20%	22.00%	21.00%
Earnings Yield	8.88%	14.31%	22.87%	24.18%	20.73%	24.28%
FCF Yield	-	15.37%	22.34%	31.73%	22.03%	39.84%
Dividend Yield	4.43%	7.56%	11.28%	9.69%	9.38%	13.43%
Payout Ratio	-	74.75%	41.59%	18.67%	33.56%	26.36%
Buyback Yield / Dilution	-6.04%	-4.12%	-0.91%	1.58%	1.54%	4.35%
Total Shareholder Return	-1.61%	3.44%	10.37%	11.27%	10.92%	17.78%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.